TY - JOUR
T1 - Occurrence of depression and anxiety prior to Parkinson's disease
AU - Jacob, E. L.
AU - Gatto, N. M.
AU - Thompson, A.
AU - Bordelon, Y.
AU - Ritz, B.
PY - 2010/11/1
Y1 - 2010/11/1
N2 - Objective: To assess the relationship between depression and anxiety and Parkinson's disease (PD). Background: Many people with PD suffer from depression and anxiety prior to the onset of motor symptoms. Studies suggest these psychiatric conditions may be risk factors for PD or prodromal non-motor symptoms. Methods: Using a population-based approach in three California counties, we recruited 371 incident PD cases, 402 population and 115 sibling controls. We recorded self-reports of lifetime depression/anxiety diagnoses and use of psychotropic medications. We adjusted for age, race, sex, pack-years of smoking, and education, and also conducted analyses after excluding (lagging) both diagnoses and medication use first occurring within 2, 5, 10, and 20 years of the index/diagnosis date. Results: Cases were more likely to have received a diagnosis of depression or anxiety at any time prior to index date (OR 1.42, 95% CI 1.01, 2.00), but were not more likely to have been both diagnosed and treated (OR 1.11, 95% CI 0.77, 1.60). Male PD patients received diagnoses combined with treatment more often than population controls within 5 years of PD diagnosis (OR 2.21, 95% CI 1.21, 4.04; 2 year lag: OR 2.44, 95% CI 1.29, 4.61; 5 year lag: OR 1.67, 95% CI 0.80, 3.49). We did not see any differences for females. Results for cases compared to sibling controls were similar to those for population controls. Conclusion: These results suggest that depression and anxiety may be early symptoms during the prodromal phase of PD.
AB - Objective: To assess the relationship between depression and anxiety and Parkinson's disease (PD). Background: Many people with PD suffer from depression and anxiety prior to the onset of motor symptoms. Studies suggest these psychiatric conditions may be risk factors for PD or prodromal non-motor symptoms. Methods: Using a population-based approach in three California counties, we recruited 371 incident PD cases, 402 population and 115 sibling controls. We recorded self-reports of lifetime depression/anxiety diagnoses and use of psychotropic medications. We adjusted for age, race, sex, pack-years of smoking, and education, and also conducted analyses after excluding (lagging) both diagnoses and medication use first occurring within 2, 5, 10, and 20 years of the index/diagnosis date. Results: Cases were more likely to have received a diagnosis of depression or anxiety at any time prior to index date (OR 1.42, 95% CI 1.01, 2.00), but were not more likely to have been both diagnosed and treated (OR 1.11, 95% CI 0.77, 1.60). Male PD patients received diagnoses combined with treatment more often than population controls within 5 years of PD diagnosis (OR 2.21, 95% CI 1.21, 4.04; 2 year lag: OR 2.44, 95% CI 1.29, 4.61; 5 year lag: OR 1.67, 95% CI 0.80, 3.49). We did not see any differences for females. Results for cases compared to sibling controls were similar to those for population controls. Conclusion: These results suggest that depression and anxiety may be early symptoms during the prodromal phase of PD.
KW - Case control study
KW - Depression
KW - Parkinson's disease
KW - Pre-motor phase
KW - Risk factors in epidemiology
UR - http://www.scopus.com/inward/record.url?scp=77958153385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77958153385&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2010.06.014
DO - 10.1016/j.parkreldis.2010.06.014
M3 - Article
C2 - 20674460
AN - SCOPUS:77958153385
VL - 16
SP - 576
EP - 581
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
SN - 1353-8020
IS - 9
ER -